// App-Quantinova.ai

1230-324 : PATIENTS WITH CORONARY DISEASE WITHOUT TRADITIONAL RISK FACTORS SHOW A MORE FAVORABLE PROFILE OF BIOMARKERS RELATED TO MINERAL METABOLISM, INFLAMMATION AND HEART FAILURE

Researchers

Presenter

  • Ana Maria Pello

Principal Investigators

  • Carmen Cristobal

  • Nieves Tarin

  • Jesus Egido

  • Ana Huelmos

  • Oscar Lorenzo

  • Juan Antonio Franco Pelaez

  • alvaro Acena

  • Rocio Carda

  • Jeronimo Farre

  • Ignacio Mahillo

  • Joaquin Alonso

Medical Centers

  • Fundacion Jimenez Diaz, Madrid, Spain

Locations

  • Spain

Companies

  • N/A

Study Components

Therapeutic Area

  • Central Nervous System (CNS)

Disease

  • Transient Ischemic Attack

  • Coronary Artery Disease

  • Congestive heart failure

  • Dyslipidemia

  • Hypertension

  • Diabetes

  • Stroke

Biomarkers

  • C-C Motif Chemokine Ligand 2

  • C reactive protein

  • Fibroblast growth factor 23

  • Galectin-3

  • High sensitivity C-reactive protein

Drug/Treatment

  • Ergocalciferol

  • Calcifediol

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved